Celltrion companies shares rally on test kit procurement deal in U.S.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Celltrion announced on Thursday that Celltrion USA was picked as a supplier by the Defense Logistics Agency (DLA) to provide its rapid Covid-19 test kit named DiaTrust™ to 25,000 major facilities including military bases, community testing stations and long-term care facilities by September 16, 2022. The deal value could reach $626 million, the largest among the suppliers.
On Thursday, Kospi-listed Celltrion shares gained 3.27 percent to end at 284,500 won. Kosdaq-listed Celltrion Pharm jumped 6.77 percent to 164,000 won and Celltrion Healthcare up 1.78 percent to 119,800 won.
Diatrust jointly developed by Celltrion and Humasis was authorized for emergency use by the U.S. Food and Drug Administration (FDA) on April 16. Humasis’ large-scale manufacturing capability also helped the companies win the contract.
DiaTrust diagnoses Covid-19 infection within 15 minutes by recognizing a specific surface antigen of the virus. It features maximized sensitivity based on a 'dual antigen' method that detects both antigens. The sensitivity of the clinical results was 93.3 percent, while the specificity was 99 percent.
DiaTrust has two types – point-of-care test (POCT) for healthcare professionals and over-the-counter (OTC) for ordinary people. For the recent deal with the U.S. DLA, the company will deliver POCT kits that received the FDA emergency use authorization.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Seoul to allow individual investors to borrow stocks for 90 days for short sale - Pulse by Maeil Business News Korea
- Incheon airport operator to push ahead with $5.4 bn expansion by 2025 despite Covid woes - Pulse by Maeil Business News Korea
- Korea’s PharmGen Science to lead commercialization of world’s first Covid-19 biosimilar - Pulse by Maeil Business News Korea
- Korea starts test on hydrogen trams for commercialization by 2023 - Pulse by Maeil Business News Korea
- Celltrion companies shares rally on test kit procurement deal in U.S. - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 방시혁 ‘플랫폼 제국’ 꿈꿨지만…
- 대만 치어리더 한국스포츠 첫 진출…K리그 수원FC - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이